KleberFertrinMDPhD
Hematology • Seattle, WABlood Banking & Transfusion Medicine, Sickle Cell & Other Anemias
Assistant Professor
Dr. Fertrin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
825 Eastlake Avenue East
MS LG-700
Seattle, WA 98109Phone+1 206-606-2045Fax+1 206-606-1130- Is this information wrong?
Summary
- Dr. Kleber Fertrin is a hematologist specialized in Classical Hematology in Seattle, WA with an extensive background in Molecular Biology, Transfusion and Laboratory Medicine. His main clinical and research interests are hemolytic anemias, particularly sickle cell disease, thalassemias, iron overload, hemochromatosis, and rare diseases, such as pyruvate kinase deficiency, and variant hemoglobins.
Education & Training
NIH Clinical CenterPost-Doctoral Fellowship, NHLBI Fellowships, 2013 - 2014
University of Campinas Faculty of MedicineClass of 2003
Certifications & Licensure
WA State Medical License 2018 - 2025
Clinical Trials
- Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major Start of enrollment: 2012 Aug 01
- Hydroxyurea in the Emergency Room to Lessen Pain in Sickle Cell Crisis Start of enrollment: 2016 Nov 01
- A Study to Evaluate Efficacy and Safety of AG-348 in Not Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD) Start of enrollment: 2018 Aug 09
- Join now to see all
Publications & Presentations
PubMed
- Sickle cell disease and increased adverse maternal and perinatal outcomes in different genotypes.Camilla Olivares Figueira, José Paulo S Guida, Fernanda G Surita, Arthur Antolini-Tavares, Sara T Saad, Fernando F Costa, Maria Laura Costa, Kleber Y Fertrin> ;Hematology, Transfusion and Cell Therapy. 2024 Mar 14
- Extramedullary haematopoiesis in patients with thalassemia: a cross-sectional description of its prevalence, clinical features and survival.Eduardo Cerello Chapchap, Murilo Marques Almeida Silva, Ronaldo Hueb Baroni, Aderson da Silva Araujo, Reijane Alves de Assis, Sandra Regina Loggetto, Antonio Fabron Ju...> ;Hematology, Transfusion and Cell Therapy. 2023 Aug 26
- 24 citationsIron overload disorders.Christine C Hsu, Nizar H Senussi, Kleber Y Fertrin, Kris V Kowdley> ;Hepatology Communications. 2022 Aug 1
- Join now to see all
Abstracts/Posters
- Abnormal Cytokine Production By Mast Cell Cultures from Sickle Cell Anemia Patients in Response to Inflammatory Stimuli and to Co-Culture with EosinophilsKleber Yotsumoto Fertrin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Safe Use of Hydroxyurea in Sickle Cell Disease Patients Hospitalized for Painful Vaso-Occlusive Episodes: Results of the Randomized, Open-Label Helps StudyKleber Yotsumoto Fertrin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
Blood Clots and CancerSeptember 20th, 2023- FDA Approves Gene Editing Technology to Treat Sickle Cell Disease: HealthLinkJanuary 7th, 2024
Professional Memberships
- Member
Other Languages
- Portuguese, German
Hospital Affiliations
Fred Hutchinson Cancer CenterSeattle, Washington
External Links
- SCCA profilehttps://www.seattlecca.org/providers/kleber-fertrin
- UW profilehttps://hematology.uw.edu/faculty/kleber-yotsumoto-fertrin-md-phd
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
